Contact Us marketing@medicilon.com
Medicilon Logo
|
search icon search icon 中 contact icon menu icon
Medicilon Logo
|
search icon close search icon 中 contact icon menu icon
ABOUT
Company Profile
Corporate Culture
Management Team
Company History
Message from the CEO
Honors and Awards
Over 20 years of experience in R&D
Learn more
01 Drug Discovery
Chemistry Research
Biology Research
Early Pharmacokinetics
02 Pharmaceutical Research
Intermediates
Active Pharmaceutical Ingredients
Pharmaceutical preparation
Analytical Method Development and Quality Control
CMC Filings
Analytical Testing Center
03 Preclinical Research
Pharmacology & Pharmacodynamics
Drug Safety Evaluation
DMPK
Bioanalysis
IND Filings
01 One-stop Integrated Services
Liposome Drug Development
Drug Discovery
Pharmaceutical Research
Preclinical Research
Botanical Drug Preclinical R&D
02 Innovative Drug Services
ADC
PROTAC
mRNA Vaccine
Cellular Immunotherapies
Nucleic Acid Drug
Peptide Drug Conjugate (PDC)
Antibody
03 Key Technical Services for Drug R&D
Cytokine and Biomarker Detection
Metabolite Identification (MetID)
Drug Forming Research
Flow Cytometry Technology
SEND Format Conversion
Flow Sorting
NanoString nCounter Detection
Routes of Drug Administration
04 Drug Efficacy Evaluation for Common Diseases
IO Pharmacodynamic Model
Inflammatory and Immune Diseases
Rodent Cerebrovascular Disease
05 Advanced Preparation R&D
Inhalation drug
Ophthalmic drug
Skin Topical Preparation
06 Targeted Drugs R&D Services
STAT3-targeted Drugs R&D Service
GLP-1 New Drug R&D Service
KRAS-targeted Drugs R&D Service
CAREERS
Talent Development
Campus Recruitment
Recruitment
Campus Recruitment
Campus Recruitment
Recruitment
Recruitment
News
Medicilon Events
Featured Stories
Market Events
Videos
A.C.E.
2024-07-22Medicilon Events
The Shanghai Overseas Returned Scholars Association invites the Dutch PhD delegation to visit Medicilon, exploring paths for innovative development together
On July 4th, the Shanghai Overseas Returned Scholars Association invited the Dutch PhD delegation to visit the Chuansha campus of Shanghai Medicilon Inc. (Medicilon) and held discussions with Medicilon's Founder and CEO, Chunlin Chen, among others.
Learn more
2024-07-22Medicilon Events
5th consecutive win! Medicilon once again made the list of "Top 20 Chinese R&D CRO Enterprises in 2024"
Medicilon stood out among hundreds of pharmaceutical enterprises and was honored with the "Top 20 Chinese R&D CRO Enterprises in 2024" award.
Learn more
INVESTORS
Stock Information
Investment Contact
Medicilon 688202
RMB

As of Beijing time The data is from a third-party organization and is only for reference.

For actual information, please refer to：www.eastmoney.com

CLIENT CENTER
Intellectual Property Protection
Clients Testimonials
Downloads
Partnerships
Medicilon Support
Newsletters
U.S.

Address: 20 Maguire Road, Suite 103, Lexington, MA 02421(America)

Tel: +1(626)986-9880

UK

Address: Allia Future Business Centre Kings Hedges Road Cambridge CB4 2HY, UK

Tel: 0044 7790 816 954

Email: marketing@medicilon.com

China

Address: No.585 Chuanda Road, Pudong New Area, Shanghai (Headquarters)

Postcode: 201299

Tel: +86 (21) 5859-1500 (main line)

Fax: +86 (21) 5859-6369

Close

© 2023 Shanghai Medicilon Inc. All rights reserved Shanghai ICP No.10216606-3

Shanghai Public Network Security File No. 31011502018888 | Website Map

© 2023 Shanghai Medicilon Inc. All rights reserved Shanghai ICP No.10216606-3
Shanghai Public Network Security File No. 31011502018888|Website Map
关闭
中
Message
Contact Us
Close Button
Back To Top
Online Message×
Click switch
Close Button
News and Events
Medicilon Events Featured Stories Market Events Videos A.C.E.
HomenewsFeatured Stories

Featured Stories

Hot information：
Top 10 Global CDMO Enterprises| The Meaning of IND, NDA and ANDA| Top 10 Global Clinical Research Organizations in 2021
Sep 28,2015
A Closer Look at the Nerves That Slim Down Fat Cells
When the human body needs extra energy, the brain tells fat cells to release their stores. Now, for the first time, researchers have visualized the nerves that carry those messages from brain to fat tissue. The activation of these nerves in mice, they found, helps the rodents lose weight—an observation that could lead to newRead more
More
Sep 25,2015
Liquid Crystals Show Potential for Detection of Neurodegenerative disease
    Liquid crystals are familiar to most of us as the somewhat humdrum stuff used to make computer displays and TVs. Even for scientists, it has not been easy to find other uses. Now, scientists at the University of Chicago's Institute for Molecular Engineering are putting liquid crystals to work as detectors for the protein fibersRead more
More
Liquid Crystals Show Potential for Detection of Neurodegenerative disease
Sep 25,2015
Arming the Immune System to Against Cancer
    Researchers at Cancer Research UK say they have shown that a class of experimental drug treatments already in clinical trials could also help the body's immune system to fight cancer. They published their study ("Nuclear FAK Controls Chemokine Transcription, Tregs, and Evasion of Anti-tumor Immunity”) in Cell.     Scientists at the University of Edinburgh revealed thatRead more
More
Sep 24,2015
New Test Design Could Bring At Home Molecular Diagnostics Be Reality
    Does being able to test for allergies, STDs, or even cancer in minutes from the comfort and privacy of your home sound like science fiction? Well, a newly designed test from researchers at the University of Montreal could make it a reality before the next Star Trek movie comes to theaters.     The Canadian scientists haveRead more
More
Sep 24,2015
Protein Based Sensors Expand Synthetic Biology Repertoire
    Engineering proteins to detect specific DNA, RNA, or peptide sequences may not be a new idea, but a new approach taken by synthetic biology engineers at the Massachusetts Institute of Technology (MIT) is as interesting as it is elegant.       The MIT researchers developed a flexible system of proteins that sense particular sequences of DNA,Read more
More
Sep 23,2015
Two Genes Were Found Could Offer Gateway to Improve Therapies of Schizophrenia
    The researchers from Duke-NUS Graduate Medical School Singapore (Duke-NUS) say it has linked the abnormal behavior of two genes (BDNF and DTNBP1) to the underlying cause of schizophrenia. These findings ("Regulation of Brain-Derived Neurotrophic Factor Exocytosis and Gamma-Aminobutyric Acidergic Interneuron Synapse by the Schizophrenia Susceptibility Gene Dysbindin-1”), published in Biological Psychiatry, have provided a newRead more
More
Sep 23,2015
The DNA of Early Circulating Lung Cancer Was Found
    Working with tissue, blood, and DNA from six people with precancerous and cancerous lung lesions, scientists from Johns Hopkins say they have identified what they believe are among the very earliest premalignant genetic changes that mark the potential onset of the most common and deadliest form of disease.     In a study ("Targeted sequencing reveals clonalRead more
More
Sep 22,2015
Chinese scientists row over long-sought protein that senses magnetism
A dispute has broken out at two of China's most prestigious universities over a potentially groundbreaking discovery: the identification of a protein that may allow organisms to sense magnetic fields. On 14 September, Zhang Sheng-jia, a neuroscientist at Tsinghua University in Beijing, and his colleagues published a paper1 in Science Bulletin claiming to use magneticRead more
More
Sep 22,2015
New Technique to Better Study the Interface Where Two Cells Touch
    Since the early part of the 20th century, scientists have been trying to better understand the intricacies surrounding neuronal development. In particular, the process by which glial cells—specifically, Schwann cells—creates their fatty insulating layer that encircles the axons of peripheral neurons.  Interactions between brain cells hold the key to healthy brain function and cognition, butRead more
More
New Technique to Better Study the Interface Where Two Cells Touch
Sep 22,2015
Regeneron Announces Agreement with BARDA on Antibody Therapy for Ebola
    Regeneron Pharmaceuticals announced an agreement with the Biomedical Advanced Research and Development Authority (BARDA) of the U.S. Department of Health and Human Services (HHS) to develop, test, and manufacture a monoclonal antibody therapy for the treatment of Ebola virus infection. HHS will provide initial funding of approximately $17 million to support preclinical development and antibodyRead more
More
Stock Code
688202

Global

Address: 20 Maguire Road, Suite 103, Lexington, MA 02421(America)

Tel: +1(626)986-9880(U.S.)

Address: Allia Future Business Centre Kings Hedges Road Cambridge CB4 2HY, UK

Tel: 0044 7790 816 954 (Europe)

Email: marketing@medicilon.com

  

Address: 5th Floor, 62, Banpodae-ro 4-gil, Seocho-gu, Seoul, 06719 South Korea

Tel: +82 70-8269-5849

China

Address: No.585 Chuanda Road, Pudong New Area, Shanghai (Headquarters)

Postcode: 201299

Tel: +86 (21) 5859-1500 (main line)

Fax: +86 (21) 5859-6369

Facebook icon
Twitter icon
Linkedin icon
Youtube icon
© 2023 Shanghai Medicilon Inc. All rights reserved All Rights Reserved Privacy Policy
Website Map
-->